BENITEC BIOPHARMA INC's ticker is BNTC and the CUSIP is 08205P100. A total of 16 filers reported holding BENITEC BIOPHARMA INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $11,501 | +13.6% | 48,223 | 0.0% | 0.00% | – |
Q1 2023 | $10,122 | +126425.0% | 48,223 | -2.5% | 0.00% | – |
Q4 2022 | $8 | -100.0% | 49,469 | -18.9% | 0.00% | – |
Q3 2022 | $22,000 | -68.6% | 60,967 | +0.8% | 0.00% | – |
Q2 2022 | $70,000 | -49.6% | 60,481 | +1.5% | 0.00% | – |
Q1 2022 | $139,000 | -9.2% | 59,566 | +2.0% | 0.00% | – |
Q4 2021 | $153,000 | -19.9% | 58,413 | +8.8% | 0.00% | – |
Q3 2021 | $191,000 | +30.8% | 53,692 | +55.7% | 0.00% | – |
Q2 2021 | $146,000 | -0.7% | 34,493 | +20.8% | 0.00% | – |
Q1 2021 | $147,000 | – | 28,560 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SUVRETTA CAPITAL MANAGEMENT, LLC | 769,000 | $1,796,000 | 0.06% |
Atom Investors LP | 37,335 | $87,000 | 0.04% |
SILVERARC CAPITAL MANAGEMENT, LLC | 492,880 | $57,000 | 0.02% |
WealthTrust Axiom LLC | 12,950 | $30,000 | 0.01% |
UBS Group AG | 347 | $1,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 43 | $0 | 0.00% |
NORTHERN TRUST CORP | 11,813 | $28,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
GROUP ONE TRADING, L.P. | 2,000 | $5,000 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 59,566 | $139,000 | 0.00% |